BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37930255)

  • 1. ORAOV1, CCND1, and MIR548K Are the Driver Oncogenes of the 11q13 Amplicon in Squamous Cell Carcinoma.
    Mahieu CI; Mancini AG; Vikram EP; Planells-Palop V; Joseph NM; Tward AD
    Mol Cancer Res; 2024 Feb; 22(2):152-168. PubMed ID: 37930255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [CCND1 oncogene amplification and cellular DNA content in squamous cell carcinomas of the head and neck].
    Rodrigo Tapia JP; García González LA; Martínez Sánchez JA; González Meana MV; García Pedrero JM; Suárez Nieto C
    Acta Otorrinolaringol Esp; 2001 Oct; 52(7):539-43. PubMed ID: 11692945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ORAOV1 is amplified in oral squamous cell carcinoma.
    Xavier FC; Rodini CO; Paiva KB; Destro MF; Severino P; Moyses RA; ; Tajara EH; Nunes FD
    J Oral Pathol Med; 2012 Jan; 41(1):54-60. PubMed ID: 21623924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 (PRAD1, CCND1) and glutathione-S-transferase pi gene expression in head and neck squamous cell carcinoma.
    Gaffey MJ; Iezzoni JC; Meredith SD; Boyd JC; Stoler MH; Weiss LM; Zukerberg LR; Levine PA; Arnold A; Williams ME
    Hum Pathol; 1995 Nov; 26(11):1221-6. PubMed ID: 7590696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression.
    Akervall JA; Michalides RJ; Mineta H; Balm A; Borg A; Dictor MR; Jin Y; Loftus B; Mertens F; Wennerberg JP
    Cancer; 1997 Jan; 79(2):380-9. PubMed ID: 9010112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer.
    Zaharieva BM; Simon R; Diener PA; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Wilber K; Hering F; Schönenberger A; Flury R; Jäger P; Fehr JL; Mihatsch MJ; Gasser T; Sauter G; Toncheva DI
    J Pathol; 2003 Dec; 201(4):603-8. PubMed ID: 14648664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cytogenetic characterization of the 11q13 amplicon in head and neck squamous cell carcinoma.
    Jin C; Jin Y; Gisselsson D; Wennerberg J; Wah TS; Strömbäck B; Kwong YL; Mertens F
    Cytogenet Genome Res; 2006; 115(2):99-106. PubMed ID: 17065789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma.
    Callender T; el-Naggar AK; Lee MS; Frankenthaler R; Luna MA; Batsakis JG
    Cancer; 1994 Jul; 74(1):152-8. PubMed ID: 8004570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A region within murine chromosome 7F4, syntenic to the human 11q13 amplicon, is frequently amplified in 4NQO-induced oral cavity tumors.
    Yuan B; Oechsli MN; Hendler FJ
    Oncogene; 1997 Sep; 15(10):1161-70. PubMed ID: 9294609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MYEOV, a gene at 11q13, is coamplified with CCND1, but epigenetically inactivated in a subset of esophageal squamous cell carcinomas.
    Janssen JW; Imoto I; Inoue J; Shimada Y; Ueda M; Imamura M; Bartram CR; Inazawa J
    J Hum Genet; 2002; 47(9):460-4. PubMed ID: 12202983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A differential PCR system for the determination of CCND1 (cyclin D1) gene amplification in head and neck squamous cell carcinomas.
    Schneeberger C; Eder S; Swoboda H; Ullrich R; Zeillinger R
    Oral Oncol; 1998 Jul; 34(4):257-60. PubMed ID: 9813719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BIRC2 amplification in squamous cell carcinomas of the uterine cervix.
    Choschzick M; Tabibzada AM; Gieseking F; Woelber L; Jaenicke F; Sauter G; Simon R
    Virchows Arch; 2012 Aug; 461(2):123-8. PubMed ID: 22733500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of 11q13 region rearrangements in laryngeal squamous cell carcinoma analyzed by microarray platforms and fluorescence in situ hybridization.
    Jarmuz-Szymczak M; Pelinska K; Kostrzewska-Poczekaj M; Bembnista E; Giefing M; Brauze D; Szaumkessel M; Marszalek A; Janiszewska J; Kiwerska K; Bartochowska A; Grenman R; Szyfter W; Szyfter K
    Mol Biol Rep; 2013 Jul; 40(7):4161-71. PubMed ID: 23652995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome 11Q13 amplification in head and neck squamous cell carcinoma.
    Williams ME; Gaffey MJ; Weiss LM; Wilczynski SP; Schuuring E; Levine PA
    Arch Otolaryngol Head Neck Surg; 1993 Nov; 119(11):1238-43. PubMed ID: 8217084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma.
    Freier K; Joos S; Flechtenmacher C; Devens F; Benner A; Bosch FX; Lichter P; Hofele C
    Cancer Res; 2003 Mar; 63(6):1179-82. PubMed ID: 12649172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent amplification of ORAOV1 gene in esophageal squamous cell cancer promotes an aggressive phenotype via proline metabolism and ROS production.
    Togashi Y; Arao T; Kato H; Matsumoto K; Terashima M; Hayashi H; de Velasco MA; Fujita Y; Kimura H; Yasuda T; Shiozaki H; Nishio K
    Oncotarget; 2014 May; 5(10):2962-73. PubMed ID: 24930674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas.
    Schuuring E; Verhoeven E; Mooi WJ; Michalides RJ
    Oncogene; 1992 Feb; 7(2):355-61. PubMed ID: 1532244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene amplification and overexpression of protein phosphatase 1alpha in oral squamous cell carcinoma cell lines.
    Hsu LC; Huang X; Seasholtz S; Potter DM; Gollin SM
    Oncogene; 2006 Sep; 25(40):5517-26. PubMed ID: 16619035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCND1 amplification and cyclin D1 immunohistochemical expression in head and neck squamous cell carcinomas.
    Hanken H; Gröbe A; Cachovan G; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M
    Clin Oral Investig; 2014 Jan; 18(1):269-76. PubMed ID: 23494454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification.
    Shuster MI; Han L; Le Beau MM; Davis E; Sawicki M; Lese CM; Park NH; Colicelli J; Gollin SM
    Genes Chromosomes Cancer; 2000 Jun; 28(2):153-63. PubMed ID: 10825000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.